title: [Toward a new model of pharmacy management comprehensive care of patients with chronic kidney disease].
abstract: OBJECTIVE
  The treatment of chronic kidney disease represents 2.5% of the National Healthcare System budget. Given the panorama of economic crisis, actions aimed at containing the costs in this kind of pathologies should be implemented.
  
  
  METHODS
  Centralization of the management of the medications used for the treatment of chronic kidney disease and its complications aims at reducing the pharmaceutical expenditure.
  
  
  RESULTS
  The new contracts of public healthcare administrations with companies of dialysis centers establish a single price by which the contractor takes care of the integral management of the patients, including the dialysis therapy and pharmacological treatment. Drug management at dialysis centers will be handled by specialized pharmacists by means of the creation of pharmacy departments or drug warehouse.
  
  
  CONCLUSIONS
  these measures aim at improving healthcare of the patient in hemodialysis program, with health benefits at a lower healthcare cost.
authors.affiliation: Servicio de Nefrología. Hospital Universitario Santa Lucía. Cartagena. Murcia.. mariamurosortega@gmail.com.
authors.forename: M
authors.initials: M
authors.lastname: Muros-Ortega
authors.affiliation: Fresenius Medical Care. FMC Services Murcia. San Pedro del Pinatar. Murcia.. rosa.ramos@fmc-ag.com.
authors.forename: R
authors.initials: R
authors.lastname: Ramos
authors.affiliation: Fresenius Medical Care. Nephrocare España. Madrid.. manuel.molina4@carm.es.
authors.forename: M
authors.initials: M
authors.lastname: Molina
mesh_terms: D003191:Comprehensive Health Care; D006801:Humans; D017146:Models, Organizational; D010593:Pharmaceutical Services / Q000458:organization & administration* / Q000592:standards*; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy*